Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous t-cell lymphoma: Multinational phase II-III trial results

M. Duvic, K. Hymes, P. Heald, D. Breneman, A. G. Martin, P. Myskowski, C. Crowley, R. C. Yocum

Research output: Contribution to journal › Article › peer-review

614 Scopus citations

Fingerprint

Dive into the research topics of 'Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous t-cell lymphoma: Multinational phase II-III trial results'. Together they form a unique fingerprint.

Medicine & Life Sciences